Perspective Therapeutics (CATX) logo

Perspective Therapeutics (CATX) stock

Worth $95MShares as of Nov 4

$0.79
-8.09%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score CATX. It is priced too low for a fair Quality Score.

Healthcare · Biotech

NextQ1 2027“We are targeting an end-of-Phase 2 meeting with the FDA in 1Q 2027.”Meeting with the FDA · SEC filing · Nov 9
Cash$202M, about 7 quarters at the last year's spendingOn Sep 30 · the company says “into 2028”

Follow CATX's trial news. Pro members can get an alert when Perspective Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when CATX files news on its trialsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$202M, about 7 quarters at the last year's spendingOn Sep 30 · the company says “into 2028”

What's next for CATX, and how long its cash lasts

Next step the company has named

Q1 2027“We are targeting an end-of-Phase 2 meeting with the FDA in 1Q 2027.”Meeting with the FDA · SEC filing · Nov 9

What it means: a meeting with the FDA about the path to an application.

A trial underway
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced MelanomaPhase 1/2 · Recruiting · 300 people · main data estimated Dec 31, 2027 · NCT05655312

2 more trials, 1 more milestone and 92 filings, for Pro members.

Cash runway Sep 30 balance sheet

About 7 quarters

$202M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money. The company's estimate is “into 2028” (8-K, Nov 9).

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

  • Shelf registration (S-3ASR, filed May 24, 2024)
  • At-the-market share sales program (424B5, filed Aug 13, 2024)

For Pro members: 4 raises and their amounts, and the share count against a year ago.

Insiders

Chief Accounting Officer Jonathan Robert Hunt bought 11,000 shares on Nov 13, 2025.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and Johan Spoor’s 6 filings and quotes.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

CATX's latest filings

35 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why CATX isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. CATX trades at $0.79. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See every stock ranked

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

The price on this page is delayed at least 15 minutes.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.